NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GRI Bio, Inc. Logo
Develops NKT cell modulators for inflammatory, fibrotic, and autoimmune diseases.
United States of America
GRI
Grifols S.A. Logo
Develops and produces plasma-derived medicines and biopharmaceutical solutions.
Spain
GRF
Grindeks Logo
Vertically integrated pharmaceutical company in R&D, manufacturing, and sales.
Latvia
GRD1R
Guerbet Logo
Develops contrast media and medical devices for diagnostic and interventional imaging.
France
GBT
Specializes in biotechnology solutions and scientific instruments for R&D.
South Korea
036180
GYRE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for organ fibrosis and inflammation.
United States of America
GYRE
Haleon PLC Logo
A global consumer healthcare company focused on improving everyday health.
United Kingdom
HLN
Halychpharm Logo
A pharmaceutical manufacturer of traditional and plant-based medicinal products.
Ukraine
GFARM
Hamlet BioPharma AB Logo
Develops novel treatments for cancer and infections, with candidates in Phase II trials.
Sweden
HAMLET
HANALL BIOPHARMA CO.,LTD Logo
Biopharmaceutical firm focused on immunology, ophthalmology, and immuno-oncology.
South Korea
009420

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.